Proteasome
The proteasome is a large multisubunit complex of approximately 2.5 MDa that mediates a wide range of physiological and pathological cellular processes by selectively degrading unnecessary proteins in eukaryotes. The structure of a proteasome is comprised of the catalytic core particle (CP) and two terminal regulatory particles (RPs). The CP (also known as the 20S proteasome) is a barrel shaped multisubunit complex (approximately 750 kDa) consisting of four axially stacked heptameric rings (two outer α-rings and two inner β-rings) with 7 subunits in each ring, where three β subunits (β1, β2 and β5) contain catalytically active threonine residues and are associated with caspase-like, trypsin-like and chymotrypsin-like activities respectively.
- B6026 VR23Target: ProteasomeSummary: proteasome inhibitor
- A1933 Carfilzomib (PR-171)10 CitationTarget: ProteasomeSummary: Proteasome inhibitor, epoxomicin analog
- A8179 MG-2621 CitationTarget: ProteasomeSummary: Proteasome inhibitor
- A4007 MLN97083 CitationTarget: ProteasomeSummary: Proteasome inhibitor
- A2604 CelastrolTarget: ProteasomeSummary: Antioxidant, anti-inflammatory and immunosuppressive agent
- A2583 Lactacystin (Synthetic)1 CitationTarget: ProteasomeSummary: Proteasome inhibitor
- A2585 MG-13226 CitationTarget: ProteasomeSummary: Proteasome inhibitor, Cell permeable, reversible
- A4011 ONX-0914 (PR-957)6 CitationTarget: ProteasomeSummary: Immunoproteasome inhibitor,potent and selective
- A4010 Salinosporamide A (NPI-0052, Marizomib)Target: ProteasomeSummary: 20S proteasome inhibitor
- A2612 MG-1151 CitationTarget: ProteasomeSummary: Potent reversible proteasome inhibitor